CP1.AX - Cannpal Animal Therapeutics Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 58.66M
Enterprise value 35.78M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)13.23
Price/book (mrq)3.10
Enterprise value/revenue 38.83
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 3-38.00%
S&P500 52-week change 310.93%
52-week high 30.2000
52-week low 30.0690
50-day moving average 30.0924
200-day moving average 30.1138

Share statistics

Avg vol (3-month) 339.5k
Avg vol (10-day) 356.46k
Shares outstanding 593.12M
Float 57.02M
% held by insiders 140.31%
% held by institutions 119.61%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2019
Most-recent quarter (mrq)31 Dec 2019

Profitability

Profit margin -276.96%
Operating margin (ttm)-291.21%

Management effectiveness

Return on assets (ttm)-31.01%
Return on equity (ttm)-50.40%

Income statement

Revenue (ttm)654.42k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)120.10%
Gross profit (ttm)-1.26M
EBITDA N/A
Net income avi to common (ttm)-1.81M
Diluted EPS (ttm)-0.0190
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.42M
Total cash per share (mrq)0.03
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)9.24
Book value per share (mrq)0.03

Cash flow statement

Operating cash flow (ttm)-2.14M
Levered free cash flow (ttm)-1.52M